Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 211 AL 225

Anti-Amyloid Therapies for Alzheimer's Disease: Progress, Pitfalls, and the Path Ahead

Papaliagkas V.

Int J Mol Sci. 2025 Sep 29;26(19):9529. doi: 10.3390/ijms26199529.

[Significance of Amyloid Plaque Removal in Alzheimer's Disease Treatment: Development of Amyloid β-Targeting Antibody Drugs Based on the Amyloid Cascade Hypothesis]

Kowa H, Sato S, Kamiki E, Nishimoto T.

Brain Nerve. 2025 Oct;77(10):1129-1136. doi: 10.11477/mf.188160960770101129.

Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer's disease

Sahoo S, Pattanaik S, Kar DM, Prusty SK, Sahu PK.

Gene. 2025 Nov 20;972:149827. doi: 10.1016/j.gene.2025.149827. Epub 2025 Oct 15.

The connection between autophagy and Alzheimer's disease

Lior N, Chen D, Dan F, Ronit PK.

Inflamm Res. 2025 Oct 22;74(1):148. doi: 10.1007/s00011-025-02118-0.

Therapeutic potential of 40 Hz flickering light stimulation in Alzheimer's disease: Mechanisms, evidence, and controversies

Wang XY, Jia YJ, Zhang J, Chen JF, Wang YJ, Chen X.

J Alzheimers Dis. 2025 Dec;108(4):1441-1451. doi: 10.1177/13872877251388664. Epub 2025 Oct 22.

Exploring the role of insulin resistance in bridging the metabolic syndrome and Alzheimer's disease-a review of mechanistic studies

Wang S, Shi Y, Xin R, Kang H, Xiong H, Ren J.

Front Endocrinol (Lausanne). 2025 Oct 8;16:1614006. doi: 10.3389/fendo.2025.1614006. eCollection 2025.

Active immunization: A novel therapeutic strategy for treating Alzheimer's disease

Mazahir F.

Eur J Pharmacol. 2025 Nov 15;1007:178288. doi: 10.1016/j.ejphar.2025.178288. Epub 2025 Oct 24.

Alzheimer Combination Therapies: Overview and Scenarios

Cummings JL, Burstein AH, Fillit H.

J Prev Alzheimers Dis. 2025 Dec;12(10):100328. doi: 10.1016/j.tjpad.2025.100328. Epub 2025 Oct 27.

Add-on combination therapy with monoclonal antibodies: Implications for drug development

Cummings J, Burstein AH, Fillit H.

J Prev Alzheimers Dis. 2025 Dec;12(10):100359. doi: 10.1016/j.tjpad.2025.100359. Epub 2025 Oct 27.

Influence of the Gut Microbiota on the Pathogenesis of Alzheimer's Disease: A Literature Review

Koga-Batko J, Antosz-Popiołek K, Suchecki W, Szyller H, Wrześniewska M, Dyda M, Leszek J.

Cells. 2025 Oct 11;14(20):1578. doi: 10.3390/cells14201578.

Premenstrual dysphoric disorder as a potential predisposing factor for Alzheimer's disease: a review

Yang J, Cheng M, Jiang Z, Du C, Zhao J, Luo Z, Zhang Z.

Front Endocrinol (Lausanne). 2025 Oct 14;16:1580947. doi: 10.3389/fendo.2025.1580947. eCollection 2025.

Peripheral immune and metabolic regulation of Aβ and Tau by exercise in Alzheimer's disease

Yu Y, Chen K.

Front Immunol. 2025 Oct 15;16:1678526. doi: 10.3389/fimmu.2025.1678526. eCollection 2025.

Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer's disease

Vanya, Kumari S, Bagri K, Deshmukh R.

Neuroscience. 2025 Dec 5;590:170-185. doi: 10.1016/j.neuroscience.2025.10.050. Epub 2025 Oct 31.

Tau Liquid-Liquid Phase Separation in Alzheimer's Disease: Mechanisms, Pathogenesis, and Therapeutic Implications

Tian S, Liu Y, Hu H, Li S.

Mol Neurobiol. 2025 Nov 9;63(1):18. doi: 10.1007/s12035-025-05280-y.

APOE-Targeted Therapeutics for Alzheimer's Disease

Yassine HN, Hugo C, O'Donovan B, Stephens IO, Johnson LA, Cole G, Tcw J, Johansson J, Kisler K, Chiba-Falek O.

J Neurosci. 2025 Nov 12;45(46):e1388252025. doi: 10.1523/JNEUROSCI.1388-25.2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias